semustine has been researched along with Remission, Spontaneous in 18 studies
Semustine: 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
semustine : An organochlorine compound that is urea in which the two hydrogens on one of the amino groups are replaced by nitroso and 2-chloroethyl groups and one hydrogen from the other amino group is replaced by a 4-methylcyclohexyl group.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
Excerpt | Relevance | Reference |
---|---|---|
"The combination of vincristine, methyl-CCNU, and methotrexate with or without MER-BCG achieved a 2% complete response (CR) and a 11% partial response (PR) with a median duration of 25-29 weeks in 124 evaluable patients with advanced adenocarcinoma of the colon and rectum." | 5.04 | Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum: a prospective randomized study. ( Barnes, P; Cooper, R; Howard, V; Muss, HB; Rhyne, L; Richards, F; Spurr, CL; Stuart, JJ; White, DR, 1979) |
" Hematologic toxicity, however, was significantly different, with earlier time to the most severe blood count depressions, more frequent occurrence of severe depression, and a larger percentage of patients requiring dosage reduction on the 6-week regimen." | 2.65 | A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments. ( DeWys, WD; Khandekar, JD; Kosova, LA; Perlia, CP; Slayton, RE; Taylor, SG; Wolter, J, 1979) |
"Fifty-two untreated patients with colorectal cancer were randomized to receive 5-fluorouracil (5-FU) alternating either with methotrexate (MTX) or Baker's Antifol (BAF) with or without the immunostimulant, levamisole (Program I)." | 2.64 | Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole. ( Bedikian, AY; Bodey, GP; Burgess, MA; Mavligit, GM; Rodriguez, V; Valdivieso, M, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Livingston, RB | 1 |
Falkson, G | 2 |
Moertel, CG | 2 |
Lavin, P | 1 |
Pretorius, FJ | 1 |
Carbone, PP | 1 |
Avellanosa, AM | 1 |
West, CR | 1 |
Tsukada, Y | 1 |
Higby, DJ | 1 |
Bakshi, S | 1 |
Reese, PA | 1 |
Jennings, E | 1 |
Hrushesky, WJ | 1 |
Murphy, GP | 1 |
Costanza, ME | 1 |
Nathanson, L | 1 |
Schoenfeld, D | 1 |
Wolter, J | 2 |
Colsky, J | 1 |
Regelson, W | 1 |
Cunningham, T | 1 |
Sedransk, N | 1 |
Abdallah, AM | 1 |
Soukop, M | 1 |
Bell, G | 1 |
Calman, KC | 1 |
Maurice, P | 1 |
Glidewell, O | 1 |
Jacquillat, C | 1 |
Silver, RT | 1 |
Carey, R | 1 |
Pas, AT | 1 |
Cornell, CJ | 1 |
Burningham, RA | 1 |
Nissen, NI | 1 |
Holland, JF | 1 |
Buroker, T | 2 |
Kim, PN | 2 |
Groppe, C | 2 |
McCracken, J | 2 |
O'Bryan, R | 2 |
Panettiere, F | 2 |
Coltman, C | 1 |
Bottomley, R | 2 |
Wilson, H | 1 |
Bonnet, J | 2 |
Thigpen, T | 2 |
Vaitkevicius, VK | 3 |
Hoogstraten, B | 2 |
Heilbrun, L | 2 |
Kokoschka, EM | 1 |
Luger, T | 1 |
Micksche, M | 1 |
Bedikian, AY | 1 |
Valdivieso, M | 1 |
Mavligit, GM | 1 |
Burgess, MA | 1 |
Rodriguez, V | 1 |
Bodey, GP | 1 |
Kemeny, N | 1 |
Yagoda, A | 1 |
Braun, D | 1 |
Golbey, R | 1 |
Richards, F | 1 |
Muss, HB | 1 |
Cooper, R | 1 |
White, DR | 1 |
Stuart, JJ | 1 |
Howard, V | 1 |
Barnes, P | 1 |
Rhyne, L | 1 |
Spurr, CL | 1 |
Taylor, SG | 1 |
DeWys, WD | 1 |
Perlia, CP | 1 |
Slayton, RE | 1 |
Kosova, LA | 1 |
Khandekar, JD | 1 |
Costanzi, J | 1 |
King, GW | 1 |
Whitecar, J | 1 |
Haas, C | 1 |
Baker, LH | 1 |
Talley, RW | 1 |
Matter, R | 1 |
Lehane, DE | 1 |
Ruffner, BW | 1 |
Jones, SE | 1 |
Morrison, FS | 1 |
Stephens, RL | 1 |
Gehan, EA | 1 |
Falkson, HC | 1 |
Cedermark, BJ | 1 |
Kaufman, JH | 1 |
Douglass, HO | 1 |
Mittelman, A | 1 |
1 review available for semustine and Remission, Spontaneous
Article | Year |
---|---|
Current status of the therapy of advanced renal carcinoma.
Topics: Adenocarcinoma; Androgens; Animals; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans | 1977 |
15 trials available for semustine and Remission, Spontaneous
Article | Year |
---|---|
Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamid | 1977 |
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial.
Topics: Adenoma, Bile Duct; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Clinical Trials a | 1978 |
Results with methyl-CCNU and DTIC in metastatic melanoma.
Topics: Brain Neoplasms; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dacarbazine; Drug | 1977 |
A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorourac | 1977 |
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
Topics: Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Lymphoma, Non-Hodg | 1978 |
5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Bone Marrow; Clinical Trials as Topic; Colonic Neoplasms; Female; Fluorouracil; Huma | 1978 |
[Immuno-chemotherapy in patients with disseminated metastasizing stage III melanoma. Randomized study with methyl-CCNU versus C. parvum plus methyl-CCNU].
Topics: Bacterial Vaccines; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Nitrosourea Compo | 1978 |
Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Colonic Neopl | 1978 |
A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Colonic Neoplasms; Digestive System; D | 1979 |
Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum: a prospective randomized study.
Topics: Adenocarcinoma; Antineoplastic Agents; BCG Vaccine; Clinical Trials as Topic; Colonic Neoplasms; Dru | 1979 |
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Bone Marrow; Clinical Trials as Topic; Drug Administration | 1979 |
5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
Topics: Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Drug Therapy, Combination; Female; Flu | 1979 |
Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; | 1976 |
Fluorouracil, methyl-CCNU and vincristine in cancer of the colon.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Neopla | 1976 |
Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Deoxyribonucleosides; Drug Therapy, Combination; Fem | 1977 |
2 other studies available for semustine and Remission, Spontaneous
Article | Year |
---|---|
Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Brain Neoplasms; Drug Evaluation; Drug Therapy, Com | 1979 |
Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
Topics: Carmustine; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Gastrointestinal Neo | 1976 |